AB239. SOH26AB_0166. Audit of prophylactic clexane prescription: are we dose adjusting correctly based on weight?

Subcutaneous low molecular weight heparin (LMWH) is routinely prescribed for surgical patients upon admission to the hospital as thromboprophylaxis. Local guidelines require dose adjustment based on patient weight and renal function. Incorrect dosing can put patients at an increased risk of deep venous thrombosis (DVT) and pulmonary embolism (PE) or bleeding if they are under- or over-dosed on LMWH, respectively. This audit aimed to assess compliance with guideline-based dose adjustment of LMWH and identify areas for improvement.